BlackRock Health Sciences Term Trust Proxy Statement Filed

TL;DR

BlackRock Health Sciences Term Trust filed its proxy statement, shareholders need to vote.

AI Summary

BlackRock Health Sciences Term Trust filed a Definitive Proxy Statement (DEFA14A) on June 10, 2024. This filing concerns the solicitation of proxies from shareholders. The company, formerly known as BlackRock Health Sciences Trust II, is incorporated in Maryland and has its fiscal year end on December 31.

Why It Matters

This filing is important for shareholders as it outlines the information and proposals for which their proxy votes are being solicited, impacting corporate governance and decision-making.

Risk Assessment

Risk Level: low — This is a routine proxy filing for a publicly traded trust, not indicating any immediate financial distress or significant operational changes.

Key Players & Entities

• BlackRock Health Sciences Term Trust (company) — Registrant
• BlackRock Health Sciences Trust II (company) — Former company name
• 20240610 (date) — Filing date
• 1231 (date) — Fiscal year end

FAQ

Filing Documents

• d759879ddefa14a.htm (DEFA14A) — 11KB
• 0001193125-24-157563.txt ( ) — 12KB

From the Filing

HEALTH SCIENCES TERM TRUST BLACKROCK HEALTH SCIENCES TERM TRUST UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Definitive Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 BLACKROCK HEALTH SCIENCES TERM TRUST (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11. BlackRock Advisors, LLC sent the following email to certain shareholders: Dear [], As you know, ten of our closed-end funds (ECAT, BIGZ, BMEZ, BCAT, BSTZ, BFZ, MPA, BNY, MHN, MYN) have important shareholder votes coming up. I encourage you to vote all of the shares that you own in these funds as soon as possible in line with the Boards recommendations. You can vote by going to www.proxyvote.com and use the control number on the Voting Instruction Form (VIF). You should have received the VIF previously in the mail or via email: A sample VIF is attached this is not your actual VIF form. The control number is in a box in the top right corner of the VIF and has an arrow pointing to it. Please ensure that you use the VIF that states WHITE VOTING INSTRUCTION FORM. A holder cannot support the fund if they use the form titled GOLD VOTING INSTRUCTION FORM. You can also vote via touchtone by calling the tollfree number on your VIF. You will need the control number described above. We do not have access to control numbers. For security purposes, only the shareholder and their brokerage firm get access to control numbers. If you dont have the VIF, you can obtain your control number by asking your brokerage firm for it. Again, it is important that you ask for the MANAGEMENT or WHITE control number on the WHITE VOTING INSTRUCTION FORM (VIF). The Funds and Saba each have their own form of VIF / proxy card so its really important that you request the control number on the WHITE VIF. Should you have any questions, please contact [].

View Full Filing

View this DEFA14A filing on SEC EDGAR